tiprankstipranks
Advertisement
Advertisement

LLY Stock Latest News

M&A News: Eli Lilly (LLY) Expands Into Painkiller Market with Latest Acquisition
Market NewsM&A News: Eli Lilly (LLY) Expands Into Painkiller Market with Latest Acquisition
8m ago
LLY
Eli Lilly Advances New Early‑Stage Drug With Fresh Clinical Trial Update
PremiumCompany Announcements
Eli Lilly Advances New Early‑Stage Drug With Fresh Clinical Trial Update
3h ago
LLY
Eli Lilly Advances LY4395089 With New Drug–Drug Interaction Study
PremiumCompany Announcements
Eli Lilly Advances LY4395089 With New Drug–Drug Interaction Study
3h ago
LLY
Eli Lilly Advances New Alzheimer’s Drug LY3439539 Into Phase 1: What Investors Should Watch
PremiumCompany Announcements
Eli Lilly Advances New Alzheimer’s Drug LY3439539 Into Phase 1: What Investors Should Watch
3h ago
LLY
Eli Lilly Advances New Oral Candidate With Fresh Phase 1 Bioavailability Study
PremiumCompany Announcements
Eli Lilly Advances New Oral Candidate With Fresh Phase 1 Bioavailability Study
3h ago
LLY
DELL Stock Pulled Back. The AI Backlog Keeps Building
PremiumMarket NewsDELL Stock Pulled Back. The AI Backlog Keeps Building
6h ago
HON
LLY
Eli Lilly acquires 4E Therapeutics, terms not disclosed
Premium
The Fly
Eli Lilly acquires 4E Therapeutics, terms not disclosed
6h ago
LLY
Ten Structural Traits That Define a Monopoly: Inside the Screen Behind the Strategy Shares Monopoly ETF (MPLY)
Premium
Market NewsSponsored
Ten Structural Traits That Define a Monopoly: Inside the Screen Behind the Strategy Shares Monopoly ETF (MPLY)
7h ago
V
MA
Novo Nordisk Seeks China Approval for Wegovy Pill, Intensifying Rivalry with Lilly
PremiumMarket News
Novo Nordisk Seeks China Approval for Wegovy Pill, Intensifying Rivalry with Lilly
12h ago
LLY
NVO
CMS proposes to lock in lower prices in Medicare drug price negotiation program
PremiumThe Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
1d ago
AZN
BMY
Eli Lilly announces new data from Phase 1 AJX-101 study
PremiumThe Fly
Eli Lilly announces new data from Phase 1 AJX-101 study
2d ago
LLY
Eli Lilly announces Phase 3 BRUIN CLL-322 trial met primary endpoint
PremiumThe Fly
Eli Lilly announces Phase 3 BRUIN CLL-322 trial met primary endpoint
2d ago
LLY
Eli Lilly Stock (LLY) Dips on Reports Employers Plan to Drop Weight-Loss Drug Coverage
PremiumMarket NewsEli Lilly Stock (LLY) Dips on Reports Employers Plan to Drop Weight-Loss Drug Coverage
4d ago
CI
LLY
Eli Lilly Launches New Phase 2 Bet on Chronic Low Back Pain Relief
Premium
Company Announcements
Eli Lilly Launches New Phase 2 Bet on Chronic Low Back Pain Relief
5d ago
LLY
Eli Lilly Expands Chronic Pain Pipeline With New Osteoarthritis Trial
Premium
Company Announcements
Eli Lilly Expands Chronic Pain Pipeline With New Osteoarthritis Trial
5d ago
LLY
Employers considering dropping coverage of GLP-1 drugs in 2027, Reuters reports
PremiumThe Fly
Employers considering dropping coverage of GLP-1 drugs in 2027, Reuters reports
5d ago
CI
LLY
Lilly’s Brenipatide Trial Targets Depression Relapse, Opening a New Long-Term Growth Path
PremiumCompany Announcements
Lilly’s Brenipatide Trial Targets Depression Relapse, Opening a New Long-Term Growth Path
6d ago
LLY
Eli Lilly: FDA approves Ebglyss for one maintenance dose every eight weeks
PremiumThe Fly
Eli Lilly: FDA approves Ebglyss for one maintenance dose every eight weeks
7d ago
LLY
Eli Lilly price target raised to $1,350 from $1,330 at Jefferies
PremiumThe Fly
Eli Lilly price target raised to $1,350 from $1,330 at Jefferies
7d ago
LLY
Analyst Reaffirms Buy on Eli Lilly, Citing Durable Obesity Leadership and Multi‑Year Incretin Pipeline Upside
PremiumRatingsAnalyst Reaffirms Buy on Eli Lilly, Citing Durable Obesity Leadership and Multi‑Year Incretin Pipeline Upside
7d ago
LLY
Buy Rating Reiterated on Eli Lilly as Obesity Pipeline Strength Justifies Unchanged $1,283 Price Target
Premium
Ratings
Buy Rating Reiterated on Eli Lilly as Obesity Pipeline Strength Justifies Unchanged $1,283 Price Target
8d ago
LLY
Eli Lilly reports detailed results from three Phase 3 trials in ACHIEVE program
Premium
The Fly
Eli Lilly reports detailed results from three Phase 3 trials in ACHIEVE program
8d ago
LLY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >